Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients

ClinicalTrials.gov ID: NCT06836063

Public ClinicalTrials.gov record NCT06836063. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial to Evaluate Efficacy and Safety of Ropanicant in Patients With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective is to evaluate the efficacy of Ropanicant at two different dosage levels compared to placebo in patients with Major Depressive Disorder (MDD).

Study identification

NCT ID
NCT06836063
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Suven Life Sciences Limited
Industry
Enrollment
214 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 15, 2025 (Actual)
Primary completion
Feb 23, 2026 (Actual)
Completion
Feb 23, 2026 (Actual)
Last update posted
Apr 7, 2026

2025 – 2026

United States locations

U.S. sites
35
U.S. states
16
U.S. cities
34
Facility City State ZIP Site status
Woodland International Research Group LLC Little Rock Arkansas 72211 —
Woodland Research Northwest Rogers Arkansas 72758 —
Advanced Research Center, Inc. Anaheim California 92805 —
ProScience Research Group Culver City California 90230 —
Behavioral Research Specialists, LLC Glendale California 91206 —
Synergy San Diego Lemon Grove California 91945 —
Excell Research, Inc. Oceanside California 92056 —
ATP Clinical Research Orange California 92866 —
Collaborative Neuroscience Research Torrance California 90504 —
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256 —
Premier Clinical Research Institute, Inc Miami Florida 33122 —
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801 —
Panhandle Research and Medical Clinic LLC Pensacola Florida 32503 —
ForCare Clinical Research Tampa Florida 33613 —
Atlanta Center for Medical Research Atlanta Georgia 30331 —
CenExcel iResearch LLC Decatur Georgia 30030 —
CenExcel iResearch LLC Savannah Georgia 31405 —
Chicago Research Center Inc. Chicago Illinois 60634 —
Neurobehavioral Medicine Group Bloomfield Hills Michigan 48302 —
Precise Research Centers Flowood Mississippi 39232 —
Midwest Research Group Saint Charles Missouri 63304 —
Redbird Research, LLC Las Vegas Nevada 89119 —
Vector Clinical Trials Las Vegas Nevada 89128 —
Center for Emotional Fitness Cherry Hill New Jersey 08002 —
Hassman Research Institue Marlton New Jersey 08053 —
SPRI Clinical Trials, LLC Brooklyn New York 11235 —
Neurobehavioral Research Inc. Cedarhurst New York 11516 —
Richmond Behavioral Associates Staten Island New York 10312 —
Eximia Research-NC, LLC Raleigh North Carolina 27607 —
Sooner Clinical Research, Inc Oklahoma City Oklahoma 73116 —
Clinical Neuroscience Solutions Inc. Memphis Tennessee 38119 —
Community Clinical Research, Inc. Austin Texas 78754 —
North Texas Clinical Trials, LLC Fort Worth Texas 76104 —
Memorial Hermann Village Houston Texas 77043 —
Core Clinical Research Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06836063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 7, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06836063 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →